Tissue Microarrays for Rapid Linking of Molecular Changes to Clinical Endpoints
Top Cited Papers
- 1 December 2001
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 159 (6) , 2249-2256
- https://doi.org/10.1016/s0002-9440(10)63075-1
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- High-Throughput Tissue Microarray Analysis to Evaluate Genes Uncovered by cDNA Microarray Screening in Renal Cell CarcinomaThe American Journal of Pathology, 1999
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry.Journal of Clinical Pathology, 1996
- Heterogeneity of intratumour proliferative activity in primary breast cancer: Biological and clinical aspectsEuropean Journal Of Cancer, 1995
- Genetic Alterations in c-erbB-2 Protooncogene as Prognostic Markers in Human Primary Breast TumorsOncology, 1993
- Association of Overexpression of Tumor Suppressor Protien p53 With Rapid Cell Proliferation and Poor Prognosis in Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1992
- Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast CancersJNCI Journal of the National Cancer Institute, 1992
- Association of C‐erbB‐2 protein over‐expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long‐term survival in breast cancerInternational Journal of Cancer, 1991
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987